Health
Scientific Committees
Scientific Committee on Food
Outcome of discussions
Opinion of the
Scientific Committee on Food on the applicability of the
ADI (Acceptable Daily Intake) for food additives to infants
(expressed on 17/09/1998)
1. Terms of reference
To consider the applicability of the ADI
(
Acceptable
Daily
Intake) for food additives intended for use in foods
for infants in the age of 0-16 weeks.
2. Background
The 1st meeting of the Joint FAO/WHO
Expert Committee on Food Additives (JECFA) held in Rome in
December 1956 introduced the term
Acceptable
Daily
Intakes, ADI, as a tool for the safe use of food
additives. The ADI describes the daily amount of a compound
that an individual can be exposed to throughout life
without adverse effects. This concept has now been
introduced in food regulation world wide to ensure that the
ADI will not be exceeded during expected food intake by the
consumer. The introduction of this concept has also guided
the toxicological testing of food additives before they are
accepted in the food supply (SCF, 1980; JECFA, 1987). The
ongoing discussion about the predictivity and sensitivity
of the introduced testing methods, especially with regard
to the most vulnerable segments of the human population
such as young, old, immunosuppressed and pregnant leads to
continuous optimisation of the test guidelines. Presently
the question has been raised whether infants in the age of
0-16 weeks are more susceptible to chemical insults than
older children and adults. At its 1971 meeting, JECFA
expressed the opinion that children should not be exposed
to food additives before the age of 12 weeks, and that the
ADI does not apply to children below the age of 12 weeks
(WHO, 1978). The scientific support for that opinion is not
presented in any details in the report.
The SCF in its First Report on the
Essential Requirements of Infant Formulae and Follow-up
Milks Based on Cows´ Milk Proteins (Opinion expressed 27
April 1983) endorsed the principle that technological
additives should not be used in food for infants and young
children. Although the amount of additives in these foods
should be limited as far as possible, the SCF did recognise
that technological additives may contribute to the total
nutrient content and did acknowledge that the manufactures
do require a certain amount of choice to meet both
objectives. "For this reason the list of additives is
somewhat longer than at first sight might seem compatible
with the principles of non-use of additives in food for
this age group" (Comm. of EU, 1983).
In its "Opinion on Certain Additives for
Use in Infant Formulae, Follow-on Formulae and Weaning
Foods" expressed 11 December 1992 the SCF reiterates its
view that consideration of the safety of additives for use
in infant formulae, follow-on formulae and weaning foods is
a special case. The immaturity of the organs of absorption,
metabolism or excretion may mean that the distribution of
an additive in the body is different in the infant and
young child than in the adult. In addition, developing
organs and tissues may show greater sensitivity to the
effects of an additive than mature organs and tissues. The
SCF noted that infant formulae milks can constitute
virtually the entire infant diet and therefore patterns of
exposure to additives used in such formulae is very
different to the normal situation of additives approved for
general food use. For all these reasons the SCF considered
it prudent that the number and amounts of additives used in
foods for infants and young children should be kept at the
minimum necessary. The SCF confirmed its long standing view
that additives should not be permitted in foods specially
prepared for infants. Rarely, exceptional technological
circumstances may justify the use of an additive. In such
cases submissions should be accompanied by a full
justification for the use requested (Comm. of EU, 1994).
One further food additive was accepted for infant formulae,
two for follow-on formulae and one for weaning foods. In
1996 the SCF adopted an opinion on additives in nutrient
preparations for use in infant formulae, follow-on formulae
and weaning foods based upon further information about the
functions of and justification for the use of these
additives as well as quantitative estimates of levels of
carry-over in the final food (Comm. of EU, 1997).
Carry-overs were accepted for 13 food additives in infant
formulae, follow-on formulae and weaning foods
3. Biological differences between infants on the one
side and children and adults on the other which may
increase susceptibility of infants to chemical insults
compared to other segments of the population.
No systematic research has been
performed to address this issue, but information to assess
this question is scattered throughout the scientific
literature.
Basically infants are in a progressive
stage of development and growth. Infants do have a higher
metabolic rate than children and adults. The relative
weight gain during the first 6 months of life is higher
than during any other period in life. In consequence, the
oxygen consumption and the requirement for energy and fluid
is greater in infants than in children and adults (Plunkett
et al. in Guzelian et al., 1992).
In the new born infant, gastric pH is
relatively high and only reaches acidity at several months
of age. This means that the ionisation state of chemicals
in the gastrointestinal tract and consequently the
possibility for passage of chemicals into the body will be
different in the infant compared with older
children.
Protein binding in the newborn is low,
which means that the amount of free chemical which is the
active form could be greater (Snodgrass in Guzelian et al.
1992). The volume of distribution for the chemical in a
premature infant may be twice as large as than of an adult.
The newborn infant has a high water content, which may
reach 85 per cent in the premature infant, against 50 per
cent in the adult (Plunkett et al., in Guzelian et al.
1992).
The infant only reaches adult levels of
most enzyme systems by 2-3 months of age. A low capacity to
metabolise xenobiotics may thus make the infant less able
to detoxify chemicals and consequently more susceptible to
toxicants. However, the metabolites of the chemicals may
sometimes be more toxic than the parent compounds and in
such cases the low metabolic capacity may actually protect
the infant against toxicity, e.g. acetaminophen
hepatotoxicity (Kaufmann, 1992).
The renal excretion depends on the
maturation of the kidney. The glomerular filtration is slow
in new-born infants (30-40 per cent of adult values) but
increases to adult value by 1/2-1 year of age. Tubular
secretion is also lower in infants than in adults. This is
counteracted by the low ability to concentrate urine which
only reaches adult value at 16 months.
Certain drug receptors are not developed
in the infant and chemicals may produce opposite effects in
infants and adults, e.g. phenobarbital (Kacew,
1992).
Epidemiological data show that the
development of allergy from oral sensitisation apparently
occurs only within the first year of life. The special
sensitivity of infants may be related both to an increased
uptake of allergens, and immaturity of the local and
systemic immunological responses. The mechanism is not
fully understood (Vos et al., 1996). Since several
components of the immune system are not fully developed at
birth it is possible that chemicals may interfere with the
development of this system (Schilter et al., 1996).
During early development substances with
hormone like effects may have profound effects in both
sexes (Chapin et al, 1996; Toppari et al, 1996).
Brain weight at birth is about one third
of adult weight, and 75 per cent after two years. The blood
brain barrier is not complete until around 6 months after
birth. The development of the brain takes place over a much
longer time span than other organs. Cell migration to the
cerebral cortex, hippocampus and cerebellum is not
completed until several months after birth. Because of the
very long and complex developmental phase of the brain, and
the very grave consequences for the individual with
impaired brain function, it is important that the unharmed
development of this organ receives great attention.
Differences in toxicokinetics between
infants and children and adults have been studied in an
extensive database on the
in vivo pharmacokinetics of therapeutic drugs
(Renwick, 1997). From this database it is concluded that
the elimination/clearance of the drugs examined is either
similar to or in many cases higher in infants (or children)
compared to adults and that this difference would apply to
other xenobiotics.
Thus the most important biological
differences between infants and children/adults do not
relate in general to the toxicokinetics of xenobiotics, but
to the toxicodynamics of these compounds especially because
of the immaturity of the cells and tissues and their rapid
growth in infants.
4. Relevance of the toxicity data package presently
required by the SCF for food additives, to the exposure
situation of infants.
The SCF has listed its requirement for
toxicity data for food additives in its report on
guidelines for the safety assessment of food additives
expressed 22 February 1980 (Comm. of EU, 1980). In this
report SCF also explained its principles for performing the
safety assessment leading to the ADI. The
no-observed-adverse-effect-level (the NOAEL) in the
most sensitive experiment among the studies performed with
the test compound is identified and this value is divided
with 100 to establish the
acceptable daily intake (the ADI) expressed in mg
per kg body weight per day, which may be ingested over
lifetime. The SCF does underline that the establishment of
the ADI is not a mechanical procedure but the result of a
thorough
case-by-case procedure taking into account the
biological properties of the individual food additive. This
includes the possibility that the biologically most
sensitive period for a compound is only a very short period
in a certain phase of the life of the individual, and that
the ADI derived in this case therefore may be
over-protective for the majority of the population.
The mammalian guideline studies for
chronic toxicity and carcinogenicity allow detection of
effects in animals being exposed soon after weaning. In
standard reproductive toxicity and developmental toxicity
studies, animals are exposed
in utero and during lactation, reflecting the human
situation. Since the structure of the placenta and the rate
of foetal and perinatal development differ between species,
these differences impose the need for the use of the
traditional safety factor accounting for species
differences.
However, if a food additive is intended
to be used in food for infants below the age of 16 weeks a
special evaluation need to be performed, since this type of
exposure is not covered by the usual animal studies listed
above. These studies do only cover the intake through
regular food or through the mother's milk until weaning.
None of the studies usually recommended by SCF or JECFA to
assess food additives have intended to mimic an exposure
situation similar to the situation where an infant is fed
totally on infant formula.
Therefore special studies in man or
animals are recommended in order to investigate the
possible adverse effects of the direct oral exposure of the
food additives from infant formulae to infants below 16
weeks. Since the new-born rat is not developmentally
parallel to the new-born human e.g. in regard to brain
development (Ostergaard et al 1998), the studies must be
designed and interpreted with this knowledge in mind. Other
animal models should be considered. One model might be
chronic studies starting in new-born piglets raised solely
on mother's milk replacement, where the additive in
question is added at different dosage levels.
5. Conclusions and recommendations
Infants may respond differently from
adults to chemical insults, because they are in a very
progressive state of growth and development; or because of
differences in toxicodynamics or occasionally in
toxicokinetics; or because of differences in intake.
Presently available data are mostly
addressing toxicity and therapeutic effects of
pharmaceuticals, while the effects in infants of other
chemicals, including food additives, are less well
documented. Nevertheless these data indicate great
similarities in the overall outcome of the uptake/excretion
processes in infants and children/adults, while the
potential for specific toxic effects in the different
tissues are highly influenced by the faster growth and
development of the different cells and tissues in the
infants compared to older children and adults. The
potential for cellular toxicity in infants needs to be
assessed on a case-by-case basis, because toxic effects on
early cell stages and heavily dividing cells during infancy
may have different and more severe effects on the
individual later in life than toxic effects on mature cells
in the same individual imposed during adulthood when the
cells are not developing, growing and dividing to the same
extent.
The toxicological data required for food
additives and used as the basis for establishing the ADIs
covers adequately exposure during all life stages including
special emphasis on reproductive cells, on the foetus and
on the young and old organism (Comm. of EU, 1980). However,
the specific exposure situation with direct exposure of
infants to food additives due to the use in infant formulae
intended for use as the sole nutrition for infants below
the age of 16 weeks is not included in the standard
toxicity test protocols. Therefore a special evaluation
beyond the present ADI evaluation is needed before food
additives are to be accepted for use in infant formulae for
infants in the age 0-16 weeks.
6. Literature
Chapin RE, Stevens JT, Hughes CL, Kelce
WR, Hess RA, Daston GP (1996). Endocrine modulation of
reproduction. Fundamental and Applied Toxicology, Vol 29,
1-17.
Commission of the European Communities
(1980). Report of the Scientific Committee for Food on
Guidelines for the Safety Assessment of Food Additives.
(Tenth Series) [Opinion expressed 22 February 1980].
Commission of the European Communities
(1983). First Report of the Scientific Committee for Food
on the Essential Requirements of Infant Formulae and
Follow-up Milks Based on Cows´ Milk Proteins. (Fourteenth
Series) [Opinion expressed 27 April 1983].
Commission of the European Communities
(1994). Opinion on Certain Additives for Use in Infant
Formulae, Follow-on Formulae and Weaning Foods. Reports of
the Scientific Committee for Food (Thirty-second Series)
[Opinion expressed 11 December 1992].
Commission of the European Communities
(1997). Opinion on Additives in Nutrient Preparations for
Use in Infant Formulae, Follow-on Formulae and Weaning
Foods. (Fortieth Series) [Opinion expressed on 7 June
1996].
Kacew S (1992). General principles in
Pharmacology and toxicology applicable to children. In:
Guzelian PS, Henry CJ, Olin SS (Eds.): Similarities and
differences between children and adults: Implications for
risk assessment. ILSI Press, Washington D.C.
Kauffman RE (1992). Acute acetoaminophen
overdose: An example of reduced toxicity related to
developmental differences in drug metabolism. In: Guzelian
PS, Henry CJ, Olin SS (Eds.): Similarities and differences
between children and adults: Implications for risk
assessment. ILSI Press, Washington D.C.
Plunkett LM (1992). Differences between
adults and children affecting exposure assessment. In:
Guzelian PS, Henry CJ, Olin SS (Eds.): Similarities and
differences between children and adults: Implications for
risk assessment. ILSI Press, Washington D.C.
Renwick AG (1998). Toxicokinetics in
infants and children in relation to the ADI and TDI. Food
Additives and Contaminants, 15 (supl.) 17-35.
Snodgrass WR (1992). Physiological and
biochemical differences between children and adults as
determinants of toxic response to environmental pollutants.
In: Guzelian PS, Henry CJ, Olin SS (Eds.): Similarities and
differences between children and adults: Implications for
risk assessment. ILSI Press, Washington D.C.
Schilter B, Renwick AG, Huggett AC
(1996). Limits for pesticide residues in infant foods: a
safety-based proposal. Regulatory Toxicology and
Pharmacology, 24, 126-140.
Toppari J et al. (1996). Male
reproductive health and environmental chemicals with
estrogenic effects. Environmental Health Perspectives 1996,
104, 741-803.
Vos JG, Younes M, Smith E (editors)
(1996). Allergic Hypersensitivities Induced by Chemicals.
Recommendations for Prevention. Boca Raton, New York,
London, Tokyo: CRC Press.
WHO (1978). Evaluation of certain food
additives. Twenty-first report of the Joint FAO/WHO Expert
Committee on food additives. World Health Organisation,
Geneva, Technical Report series no.617.
WHO (1987). Principles for the safety
assessment of food additives and contaminants in food.
Environmental Health Criteria no. 70. World Health
Organisation, Geneva.
Ostergaard G, Knudsen I (1998). The
applicability of the ADI (Acceptable Daily Intake) for food
additives to infants and children. Food Additives and
Contaminants, 15 (suppl.), 63-74.
[
©]
- [
HEALTH] - [
SCIENTIFIC COMMITTEES] - [
SCIENTIFIC COMMITTEE ON FOOD] - [
OUTCOME OF DISCUSSIONS]
|